Display options
Share it on

Pediatr Nephrol. 2021 Sep 20; doi: 10.1007/s00467-021-05223-4. Epub 2021 Sep 20.

Growth hormone therapy in pediatric kidney transplantation-the long-term clinical benefits beyond improvement of growth after withdrawal of pre-transplant therapy.

Pediatric nephrology (Berlin, Germany)

Ryszard Grenda

Affiliations

  1. Department of Nephrology, Kidney Transplantation & Hypertension, The Children's Memorial Health Institute, Warsaw, Poland. [email protected].

PMID: 34542702 DOI: 10.1007/s00467-021-05223-4

[No abstract available.]

Keywords: Children; Chronic kidney disease; Growth hormone; Kidney transplant; rhGH

References

  1. Drube J, Wan M, Bonthuis M, Wühl E, Bacchetta J, Santos F, Grenda R, Edefonti A, Harambat J, Shroff R, Tönshoff B, Haffner D, European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders, Dialysis, and Transplantation Working Groups (2019) Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease. Nat Rev Nephrol 15:577–589. https://doi.org/10.1038/s41581-019-0161-4 - PubMed
  2. Kawaguchi H, Hattori H, Ito K (1997) Somatic and renal effects of growth hormone in rats with chronic renal failure. Pediatr Nephrol 11:280284. https://doi.org/10.1007/s004670050277 - PubMed
  3. Allen D, Fogo A, el-Hayek R, Langhough R, Friedman A (1992) Effects of prolonged growth hormone administration in rats with chronic renal insufficiency. Pediatr Res 31:406–410. https://doi.org/10.1203/00006450-199204000-00020 - PubMed
  4. Tönshoff B, Tönshoff C, Mehls O, Pinkowski J, Blum WF, Heinrich U, Stöver B, Gretz N (1992) Growth hormone treatment in children with preterminal chronic renal failure: no adverse effect on glomerular filtration rate. Eur J Pediatr 151:601–607. https://doi.org/10.1007/BF01957731 - PubMed
  5. Maxwell H, Nair DR, Dalton RN, Rigden SP, Rees L (1995) Differential effects of recombinant human growth hormone on glomerular filtration rate and renal plasma flow in chronic renal failure. Pediatr Nephrol 9:458–463. https://doi.org/10.1007/BF00866727 - PubMed
  6. Haffner D, Grund A, Leifheit-Nestler M (2021) Renal effects of growth hormone in health and in kidney disease. Pediatr Nephrol. https://doi.org/10.1007/s00467-021-05097-6 - PubMed
  7. Zhang H, Zheng Y, Liu L, Fu Q, Li J, Huang Q, Liu H, Deng R, Wang C (2016) Steroid avoidance or withdrawal regimens in paediatric kidney transplantation: a meta-analysis of randomised controlled trials. PLoS ONE 11:e0146523. https://doi.org/10.1371/journal.pone.0146523 - PubMed
  8. Wu Y, Cheng W, Yang XD, Xiang B (2013) Growth hormone improves growth in pediatric renal transplant recipients–a systemic review and meta-analysis of randomized controlled trials. Pediatr Nephrol 28:129–133. https://doi.org/10.1007/s00467-012-2208-7 - PubMed
  9. Tydén G, Berg U, Reinholt F (1990) Acute renal graft rejection after treatment with human growth hormone. Lancet 336:1455–1456. https://doi.org/10.1016/0140-6736(90)93170-t - PubMed
  10. Broyer M (1996) Results and side-effects of treating children with growth hormone after kidney transplantation -a preliminary report. Pharmacia & Upjohn Study Group. Acta Paediatr Suppl 417:76–79. https://doi.org/10.1111/j/1651-2227.1996.tb14304.x - PubMed
  11. Lebl J, Sediva A, Frisch H, Riedl S, Balzar E, Krasnicanova H (1999) Lymphocyte subsets in renal transplant recipients during growth hormone therapy. Endocr Regul 33:3–8 - PubMed
  12. Maxwell H, Amlot P, Rees L (2000) Growth hormone and markers of immune function in children with renal transplants. Pediatr Nephrol 14:473–475. https://doi.org/10.1007/s004670050795 - PubMed
  13. Melk A, Daniel V, Mehls O, Opelz G, Tönshoff B (2004) Longitudinal analysis of T-helper cell phenotypes in renal-transplant recipients undergoing growth hormone therapy. Transplantation 78:1792–1801. https://doi.org/10.1097/01.tp.0000147785.11967.1d - PubMed
  14. Benfield M, Vail A, Waldo F, Bucy R, Kohaut E (1997) The effect of rhGH in vitro on donor-specific hyporesponsiveness in pediatric transplantation. Pediatr Transplant 1:90–97 - PubMed
  15. Maxwell H, Rees L (1998) Randomised controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients. British Association for Pediatric Nephrology. Arch Dis Child 79:481–487. https://doi.org/10.1136/adc.79.6.481 - PubMed
  16. Fine RN, Stablein D (2005) Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry. Pediatr Nephrol 20:404–408. https://doi.org/10.1007/s00467-004-1688-5 - PubMed
  17. Fine RN, Stablein D, Cohen AH, Tejani A, Kohaut E (2002) Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS. Kidney Int 62:688–696. https://doi.org/10.1046/j.1523-1755.2002.00489.x - PubMed
  18. Rees L (2016) Growth hormone therapy in children with CKD after more than two decades of practice. Pediatr Nephrol 31:1421–1435. https://doi.org/10.1007/s00467-015-3179-2 - PubMed
  19. Maxwell H, Dalton RN, Nair D, Turner C, Saunders AJ, Rigden S, Rees L (1996) Effects of recombinant human growth hormone on renal function in children with renal transplants. J Pediatr 128:177–183. https://doi.org/10.1016/s0022-3476(96)70386-4 - PubMed
  20. Jagodzinski C, Mueller S, Kluck R, Froede K, Pavicic L, Gellerman J, Mueller D, Querfeld U, Haffner D, Zivicnjak M (2021) Growth hormone treatment in the pre-transplant period is associated with superior outcome after pediatric kidney transplantation. Pediatr Nephrol. https://doi.org/10.1007/s00467-021-05222-5 - PubMed
  21. Murphy WJ, Longo DL (2000) Growth hormone as an immunomodulating therapeutic agent. Immunol Today 21:211–213. https://doi.org/10.1016/s0167-5699(00)01594-2 - PubMed
  22. Welniak LA, Sun R, Murphy WJ (2002) The role of growth hormone in T-cell development and reconstitution. J Leuk Biol 71:381–387. https://doi.org/10.1189/jlb.71.3.381 - PubMed
  23. Savino W, Postel-Vinay MC, Smaniotto S, Dardenne M (2002) The thymus gland: a target organ for growth hormone. Scand J Immunol 55:442–452. https://doi.org/10.1046/j.1365-3083.2002.01077.x - PubMed
  24. Savino W, Dardenne M (2010) Pleiotropic modulation of thymic functions by growth hormone: from physiology to therapy. Curr Opin Pharmacol 10:434–442. https://doi.org/10.1016/j.coph.2010.04.002 - PubMed
  25. Weigent DA (2011) High molecular weight isoforms of growth hormone in cells of the immune system. Cell Immunol 271:44–52. https://doi.org/10.1016/j.cellimm.2011.06.001 - PubMed
  26. Lindboe JB, Langkilde A, Olsen JE, Hansen BR, BR, Petersen J, Andersen O, (2016) Low-dose growth hormone therapy reduces inflammation in HIV-infected patients: a randomized placebo-controlled study. Infect Dis (Lond) 48:829–837. https://doi.org/10.1080/23744235.2016.1201722 - PubMed
  27. Herasimtschuk A, Hansen B, Langkilde A, Moyle G, Andersen O, Imami N (2013) Low-dose growth hormone for 40 weeks induces HIV-1-specific T cell responses in patients on effective combination anti-retroviral therapy. Clin Exp Immunol 173:444–453. https://doi.org/10.1111/cei.12141 - PubMed
  28. Reynolds CM, Li M, Gray C, Vickers MH (2013) Pre-weaning growth hormone treatment ameliorates bone marrow macrophage inflammation in adult male rat offspring following maternal undernutrition. PLoS ONE 8:e68262. https://doi.org/10.1371/journal.pone.0068262 - PubMed
  29. Dharnidharka VR, Fiorina P, Harmon WE (2014) Kidney transplantation in children. N Engl J Med 371:549–558. https://doi.org/10.1056/NEJMra1314376 - PubMed

Publication Types